Abstract
Obstructive jaundice in patients over 40 years old is associated with a 4% risk of
pancreatic cancer, but only 30% of patients with pancreatic cancer present with it
[1]. This fgure rises up to 81% in patients with cancer of the pancreatic head
(Fig. 41.1a) [2]. Obstructive jaundice is a negative risk factor affecting overall survival in pancreatic cancer patients undergoing resection [2].
The management of obstructive jaundice in pancreatic head cancer has evolved
tremendously over the last century. This chapter provides a detailed discussion,
based on available evidence, for the management of obstructive jaundice in patients with pancreatic head cancer.
pancreatic cancer, but only 30% of patients with pancreatic cancer present with it
[1]. This fgure rises up to 81% in patients with cancer of the pancreatic head
(Fig. 41.1a) [2]. Obstructive jaundice is a negative risk factor affecting overall survival in pancreatic cancer patients undergoing resection [2].
The management of obstructive jaundice in pancreatic head cancer has evolved
tremendously over the last century. This chapter provides a detailed discussion,
based on available evidence, for the management of obstructive jaundice in patients with pancreatic head cancer.
| Original language | English |
|---|---|
| Title of host publication | Textbook of Pancreatic Cancer |
| Subtitle of host publication | Principles and Practice of Surgical Oncology |
| Editors | Kjetil Soreide, Stefan Stattner |
| Publisher | Springer Nature |
| Chapter | 41 |
| Pages | 631-648 |
| Number of pages | 18 |
| ISBN (Electronic) | 978-3-030-53786-9 |
| ISBN (Print) | 978-3-030-53785-2 |
| DOIs | |
| Publication status | Published - 2021 |
Keywords
- Jaundice
- Drainage
- Stent
- Endoscopic percutaneous cholangiography
- Cholangitis
- Percutaneous biliary drainag
- Morbidity
- Mortality
- Microbiology
- Outcomes